Ugwuji N. Maduekwe, MD, MMSc, MPH, FACS, FSSO

Associate Dean, Associate Professor

view physician profile

Locations

Froedtert Hospital
Cancer Center - Froedtert Hospital

Specialties

Surgical Oncology

Languages

English

Cancer Center - Froedtert Hospital

(414) 805-0505

Education

MD - Doctor of Medicine
MMSc
MPH - Masters in Public Health
FACS - Fellow of the American College of Surgeons
FSSO-Fellow of the Society of Surgical Oncology

Biography

Ugwuji N. Maduekwe, MD, MMSc, MPH, FACS is currently Associate Professor of Surgery and Director of Regional Therapies in the Division of Surgical Oncology, Department of Surgery at the Medical College of Wisconsin. Dr. Maduekwe received her undergraduate degree from The University of Texas at Dallas and her MD from Harvard Medical School. She completed her general surgery residency at the Massachusetts General Hospital in Boston followed by a Complex General Surgical Oncology fellowship at The University of Pittsburgh Medical Center. Her clinical practice is focused on the management of peritoneal surface malignancies and gastrointestinal malignancies.

Dr. Maduekwe is a member of several prestigious societies including the American College of Surgeons, the Society of Surgical Oncology, Society of Black Academic Surgeons, Association of Women Surgeons, and the Surgical Outcomes Club.

Dr. Maduekwe’s research focuses on health disparities in access to quality surgical oncology care and how that affects disparities in outcome. She has published multiple peer-reviewed articles and book chapters. She is invested in being a resource and mentor to students and residents.

Research Interests

Disparities in access to quality surgical oncology care, Cancer health equity, and outcomes in peritoneal surface malignancy therapy and management.

Surgeon Type and Anastomotic Leaks in Ovarian Cancer.

(Istl AC, Desravines N, Maduekwe UN.) JAMA Surg. 2024 Oct 01;159(10):1194-1195 PMID: 39110466 08/07/2024
Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal Cancer.

(SenthilKumar G, Merrill J, Maduekwe UN, Cloyd JM, Fournier K, Abbott DE, Zafar N, Patel S, Johnston F, Dineen S, Baumgartner J, Grotz TE, Maithel SK, Raoof M, Lambert L, Hendrix R, Kothari AN.) J Surg Res. 2023 Dec;292:275-288 PMID: 37666090 SCOPUS ID: 2-s2.0-85170090934 09/05/2023
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.

(Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB.) Ann Surg Oncol. 2023 Nov;30(12):7840-7847 PMID: 37620532 PMCID: PMC10592201 SCOPUS ID: 2-s2.0-85168622027 08/25/2023
Shared Decision-Making in the Surgical Sciences.

(Hawkins AT, Fayanju OM, Maduekwe UN.) JAMA Surg. 2023 Nov 01;158(11):1121-1122 PMID: 37466987 PMCID: PMC10824393 07/19/2023
Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis.

(SenthilKumar G, Kothari AN, Maduekwe UN, Fournier K, Abbott DE, Wilson GC, Patel SH, Greer J, Johnston F, Dineen SP, Powers BD, Baumgartner J, Veerapong J, Leiting J, Grotz TE, Maithel SK, Staley C, Raoof M, Lambert L, Lee A, Kim A, Cloyd JM, Mogal H.) Ann Surg Oncol. 2023 Sep;30(9):5743-5753 PMID: 37294386 SCOPUS ID: 2-s2.0-85161360327 06/09/2023
Identifying patient profiles of disparate care in resectable pancreas cancer using latent class analysis.

(Maduekwe UN, Stephenson BJK, Yeh JJ, Troester MA, Sanoff HK.) J Surg Oncol. 2023 Aug;128(2):254-261 PMID: 37095707 04/25/2023
Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice.

(Merrill JR, Flitcroft MA, Miller T, Beichner B, Clarke CN, Maduekwe UN, Wang TS, Dream S, Christians KK, Gamblin TC, Evans DB, Kothari AN.) J Surg Res. 2023 Aug;288:269-274 PMID: 37037166 SCOPUS ID: 2-s2.0-85151667989 04/11/2023
Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer.

(SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN.) Sci Rep. 2023 Jul 08;13(1):11051 PMID: 37422500 PMCID: PMC10329647 SCOPUS ID: 2-s2.0-85164146540 07/09/2023
Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study.

(Turner KM, Morris MC, Delman AM, Hanseman D, Johnston FM, Greer J, Walle KV, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Maduekwe U, Kothari A, Staley CA, Maithel SK, Lambert LA, Kim AC, Cloyd JM, Wilson GC, Sussman JJ, Ahmad SA, Patel SH.) J Gastrointest Surg. 2022 Dec;26(12):2569-2578 PMID: 36258061 SCOPUS ID: 2-s2.0-85140101531 10/19/2022
Surgical outcomes and survival of adrenocortical carcinoma between children and adults.

(Akinkuotu AC, Peace A, Maduekwe UN, Hayes AA.) Am J Surg. 2022 Oct;224(4):1090-1094 PMID: 35688671 PMCID: PMC10276358 06/11/2022
DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma.

(Smith MA, Van Alsten SC, Walens A, Damrauer JS, Maduekwe UN, Broaddus RR, Love MI, Troester MA, Hoadley KA.) Cancers (Basel). 2022 Sep 01;14(17) PMID: 36077818 PMCID: PMC9454479 09/10/2022
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.

(Kelly KN, Macedo FI, Seaton M, Wilson G, Hammill C, Martin RC, Maduekwe UN, Kim HJ, Maithel SK, Abbott DE, Ahmad SA, Kooby DA, Merchant NB, Datta J.) Ann Surg Oncol. 2022 Sep;29(9):6004-6012 PMID: 35511392 05/06/2022